Immune System News and Research

RSS

NYC physical therapist encourages women to incorporate physical activity to manage stress levels

Life is full of hassles, deadlines, frustrations and demands. Stress can take its toll on a woman’s health and spill into the home during the holiday season. In these economic times, tightening budgets during the ‘season to be jolly’ brings additional stress.

31 Dec 2009

Lakeshore General Hospital restricts patient visits as a result of bacterial outbreak

Lakeshore General Hospital, a West Island HSSC facility, is restricting patient visits in the 4-West medical unit as a result of a bacterial outbreak. Other services provided by this hospital centre will not be affected. This preventive measure will remain in place until January 5.

30 Dec 2009

CSL Behring awards four advocacy grants to patient organizations in the U.S.

CSL Behring, a global leader in the plasma-protein biotherapies industry and a subsidiary of CSL Limited, has awarded four advocacy grants totaling $87,000 to patient organizations in the United States through the Local Empowerment for Advocacy Development (LEAD) program.

29 Dec 2009

Advaxis reports 3-year survival data from its ADXS11-001 Phase I trial for cervical cancer

The Phase I trial of ADXS11-001, the lead vaccine candidate of Advaxis, Inc., the company that pioneered the live, attenuated Listeria monocytogenes (Lm) vaccine, has shown thirty-six (36) month survival in two (2) of the thirteen (13) evaluable patients treated with Advaxis’ therapeutic cancer vaccine, indicating the possibility of persistent immune protection, from only a two (2) dose initial regimen.

29 Dec 2009

Promising results from Soligenix' RiVax vaccine against ricin toxin

Soligenix, Inc., formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today the publication of an article in the January 2010 edition of Infection and Immunity, detailing the characteristics of several immunodominant regions of ricin A chain, the antigenic component of RiVax((TM)). RiVax((TM)) is Soligenix's vaccine to protect against exposure to ricin toxin and is currently being evaluated in Phase 1 human safety and immunogenicity trials, as well as nonhuman primate trials for efficacy.

29 Dec 2009

Nutrient-rich foods for weight loss

For the majority of Americans who are unhappy with their weight at any given moment, the New Year brings mixed emotions: the renewed resolution to shed pounds and the challenge of learning how to eat right to reach those goals.

29 Dec 2009

Nanoscaffolds could play a central role in tissue and organ reconstruction

Researchers from the University of Hong Kong and the Massachusetts Institute of Technology have published a study in the current issue of Cell Transplantation (18:9), now freely available on line at http://www.ingentaconnect.com/content/cog/ct, that explores ways to successfully keep stem cells "forever young" during implantation by slowing their growth, differentiation and proliferation.

28 Dec 2009

Infecting mosquitoes with Wolbachia bacteria increases their resistance to human disease-causing viruses

Earlier this year, researchers showed that they could cut the lives of disease-carrying mosquitoes in half by infecting them with a bacterium they took from fruit flies. Now, a new report in the December 24th issue of Cell, a Cell Press publication, suggests that their strategy might do one better: The Wolbachia bacteria also makes the mosquitoes more resistant to infection by viruses that are a growing threat to humans, including those responsible for dengue fever and Chikungunya.

28 Dec 2009

Disinfectants can promote growth of antibiotic-resistant bacteria

Using disinfectants could cause bacteria to become resistant to antibiotics as well as the disinfectant itself, according to research published in the January issue of Microbiology.

28 Dec 2009

Researchers unveil complete genetic make-up of cavity-causing bacterium

Researchers have uncovered the complete genetic make-up of the cavity-causing bacterium Bifidobacterium dentium Bd1, revealing the genetic adaptations that allow this microorganism to live and cause decay in the human oral cavity.

24 Dec 2009

Fluzone High-Dose inactivated influenza virus vaccine receives FDA approval

The U.S. Food and Drug Administration today approved Fluzone High-Dose, an inactivated influenza virus vaccine for people ages 65 years and older to prevent disease caused by influenza virus subtypes A and B.

24 Dec 2009

Gene's role in immune system may suggest new treatments for childhood asthma

Pediatric researchers have identified a novel gene involved in childhood asthma, in one of the largest gene studies to date of the common respiratory disease. Because the gene, called DENND1B, affects cells and signaling molecules thought to be instrumental in the immune system overreaction that occurs in asthma, the discovery may have singled out an important target for new treatments.

23 Dec 2009

Tips to achieve fitness and weight loss goals

More than 100 million Americans made New Year resolutions for 2009, and four out of five were not able to stick with them, according to the third annual Franklin Covey New Year’s Resolution survey released in January 2009.

23 Dec 2009

National MS Society calls for grant applications to examine the impact of CCSVI hypothesis

2009 saw exciting research progress, unprecedented opportunities on the horizon, and more scientists than ever working on resolving important questions. Despite the year's economic and financial challenges, the National Multiple Sclerosis Society continues to propel research forward to end MS. In 2009 the Society provided over $33.5 million to support 345 new and ongoing projects in its research portfolio, plus $1.5 million for Fast Forward, the Society's drug development subsidiary which continues to attract new funding streams.

23 Dec 2009

Transparency and uniformity may restore consumer trust in the insurance industry, says NIPR

During this turbulent year for the financial services industry, insurance businesses have not been immune to public scrutiny and fiscal pressures. The news of struggling holding companies leaked into the business side of insurance, creating skepticism and frustration for many policyholders who are worried about being able to plan and protect themselves and their families.

23 Dec 2009

Older adults face higher risk of hospitalization for pneumonia when exposed to pollution

Older adults with long-term exposure to higher levels of pollution are at higher risk for hospitalization for pneumonia, according to researchers in Canada.

23 Dec 2009

Enzyme dCK plays a profound role in normal lymphocyte development

Mice without the deoxycytidine kinase (dCK) enzyme have defects in their adaptive immune system, producing very low levels of both T and B lymphocytes, the major players involved in immune response, according to a study by researchers with UCLA's Jonsson Comprehensive Cancer Center.

23 Dec 2009

Researchers mix active drug and placebo to maximize drug benefits for efficient treatment

Researchers used the placebo effect to successfully treat psoriasis patients with one quarter to one half of their usual dose of a widely used steroid medication, according to an early study published online today in the journal Psychosomatic Medicine.

23 Dec 2009

Brazilian researchers perform autopsy study to examine the causes H1N1 death

Brazilian researchers have performed the first-ever autopsy study to examine the precise causes of death in victims of the H1N1 swine flu.

23 Dec 2009

Researchers develop new approach for treating and healing skin abscesses

Researchers at the Albert Einstein College of Medicine of Yeshiva University have developed a new approach for treating and healing skin abscesses caused by bacteria resistant to most antibiotics.

23 Dec 2009

Immune System News and Research

NYC physical therapist encourages women to incorporate physical activity to manage stress levels

Lakeshore General Hospital restricts patient visits as a result of bacterial outbreak

CSL Behring awards four advocacy grants to patient organizations in the U.S.

Advaxis reports 3-year survival data from its ADXS11-001 Phase I trial for cervical cancer

Promising results from Soligenix' RiVax vaccine against ricin toxin

Nutrient-rich foods for weight loss

Nanoscaffolds could play a central role in tissue and organ reconstruction

Infecting mosquitoes with Wolbachia bacteria increases their resistance to human disease-causing viruses

Disinfectants can promote growth of antibiotic-resistant bacteria

Researchers unveil complete genetic make-up of cavity-causing bacterium

Fluzone High-Dose inactivated influenza virus vaccine receives FDA approval

Gene's role in immune system may suggest new treatments for childhood asthma

Tips to achieve fitness and weight loss goals

National MS Society calls for grant applications to examine the impact of CCSVI hypothesis

Transparency and uniformity may restore consumer trust in the insurance industry, says NIPR

Older adults face higher risk of hospitalization for pneumonia when exposed to pollution

Enzyme dCK plays a profound role in normal lymphocyte development

Researchers mix active drug and placebo to maximize drug benefits for efficient treatment

Brazilian researchers perform autopsy study to examine the causes H1N1 death

Researchers develop new approach for treating and healing skin abscesses

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News